#10 Tailoring drug therapy to your genes – Qun-Ying Yue

Genetic variation is one of the reasons people differ in their
response to medicines. Understanding that variation can inform
more refined choices of drugs and doses – ultimately preventing
undesired side effects. Join us as we discuss past, present and
future of pharmacogenomics with Uppsala Monitoring Centre’s
Qun-Ying Yue.


Tune in to find out:


How genetic biomarkers can guide medicine use and dosing
recommendations

What we need to effectively implement genetic-based
prescribing in clinical practice

How increasing diversity in clinical trials can aid
pharmacogenomics research 



Want to know more?


Here are a few resources to get you started:


SWEDEGENE is a Swedish nation-wide DNA sample collection
established to facilitate pharmacogenomic studies of serious
adverse drug reactions.

The African continent, with its genetically diverse
populations, is a treasure trove of pharmacogenomics data – as
long as African patients are included in drug studies, as we
discussed in this Uppsala Reports Long Read episode.

As a past member of the European Medicines Agency’s
Pharmacogenomics Working Party, Ying contributed to the
“Guideline on key aspects for the use of pharmacogenomic
methodologies in the pharmacovigilance evaluation of medicinal
products”.

Ying also chairs ISoP’s Pharmacogenomics Special Interest
Group, whose work and objectives have been described in Uppsala
Reports and Drug Safety.






Join the conversation on social mediaFollow us on
Facebook, LinkedIn, X, or Bluesky and share your thoughts about
the show with the hashtag #DrugSafetyMatters.

Got a story to share?We’re always looking for new
content and interesting people to interview. If you have a great
idea for a show, get in touch!

About UMCRead more about Uppsala Monitoring Centre
and how we work to advance medicines safety.